Biomarkers that are present in body fluids have the potential to form the basis of affordable diagnostic tests to detect diseases in
their earliest stages and monitor disease progression (and allow vital treatment where early intervention is crucial or diagnosis currently difficult), and
neglected tropical diseases are provided here as an example.